Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof

US10844138B2 · kind B2 · utility

Assignees

• Boehringer Ingelheim International GmbH · DE
• Macrogenics, Inc. · US

Inventors

• Sanjaya Singh · Sandy Hook, US
• Qi Pan · Chappaqua, US
• Rachel Rebecca Barrett · Bethel, US
• Leslie S. Johnson · Travilah, US
• Pankaj Gupta · Scarsdale, US
• Sarah Low · Carmel, US
• Haixia Wu · Danbury, US

Key dates

• Filing date: Feb 18, 2019
• Grant date: Nov 24, 2020
• Expiry date: Feb 18, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12P21/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure relates to compounds specific for IL23A and BAFF, compositions comprising the compounds, and methods of use thereof. Nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed.